Greencoat Renewables PLC
LSE:GRP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Greencoat Renewables PLC
LSE:GRP
|
IE |
|
Carisma Therapeutics Inc
NASDAQ:CARM
|
US |
|
H
|
Hyungji Elite Inc
KRX:093240
|
KR |
|
A
|
Akobo Minerals AB (publ)
OSE:AKOBO
|
SE |
|
Anexo Group PLC
LSE:ANX
|
UK |
|
C
|
Clean Power Hydrogen PLC
LSE:CPH2
|
UK |
|
Asian American Medical Group Ltd
ASX:AJJ
|
SG |
|
Umweltbank AG
XETRA:UBK
|
DE |
|
M
|
Monsenso A/S
CSE:MONSO
|
DK |
|
Insight Enterprises Inc
NASDAQ:NSIT
|
US |
|
R
|
Radiopharm Theranostics Ltd
ASX:RAD
|
AU |
|
Hycroft Mining Holding Corporation
NASDAQ:HYMC
|
US |
Balance Sheet
Balance Sheet Decomposition
Greencoat Renewables PLC
Greencoat Renewables PLC
Balance Sheet
Greencoat Renewables PLC
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
15
|
3
|
6
|
17
|
5
|
27
|
13
|
13
|
45
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
45
|
|
| Cash Equivalents |
15
|
3
|
6
|
17
|
5
|
27
|
13
|
13
|
0
|
|
| Total Receivables |
2
|
2
|
3
|
4
|
0
|
0
|
1
|
0
|
9
|
|
| Accounts Receivables |
1
|
2
|
3
|
4
|
0
|
0
|
1
|
0
|
0
|
|
| Other Receivables |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
18
|
7
|
9
|
21
|
5
|
27
|
14
|
14
|
53
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
|
| Long-Term Investments |
317
|
757
|
850
|
944
|
1 409
|
2 110
|
2 525
|
2 403
|
2 178
|
|
| Total Assets |
335
N/A
|
764
+128%
|
859
+13%
|
965
+12%
|
1 414
+47%
|
2 137
+51%
|
2 539
+19%
|
2 417
-5%
|
2 240
-7%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
1
|
0
|
1
|
1
|
1
|
4
|
1
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
206
|
0
|
0
|
100
|
0
|
40
|
0
|
|
| Other Current Liabilities |
1
|
7
|
3
|
5
|
6
|
7
|
6
|
8
|
4
|
|
| Total Current Liabilities |
1
|
8
|
209
|
5
|
6
|
108
|
10
|
50
|
8
|
|
| Long-Term Debt |
71
|
362
|
0
|
211
|
473
|
746
|
1 250
|
1 138
|
1 130
|
|
| Total Liabilities |
72
N/A
|
370
+410%
|
209
-43%
|
216
+3%
|
479
+122%
|
854
+78%
|
1 260
+47%
|
1 187
-6%
|
1 138
-4%
|
|
| Equity | ||||||||||
| Common Stock |
3
|
4
|
6
|
7
|
9
|
11
|
11
|
11
|
11
|
|
| Retained Earnings |
247
|
270
|
258
|
234
|
258
|
328
|
1 245
|
1 219
|
1 091
|
|
| Additional Paid In Capital |
12
|
120
|
386
|
507
|
668
|
943
|
23
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
262
N/A
|
394
+50%
|
650
+65%
|
749
+15%
|
935
+25%
|
1 282
+37%
|
1 279
0%
|
1 230
-4%
|
1 102
-10%
|
|
| Total Liabilities & Equity |
335
N/A
|
764
+128%
|
859
+13%
|
965
+12%
|
1 414
+47%
|
2 137
+51%
|
2 539
+19%
|
2 417
-5%
|
2 240
-7%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
270
|
380
|
631
|
741
|
890
|
1 141
|
1 141
|
1 114
|
1 113
|
|